Quality of life after allogeneic hematopoietic cell transplantation.


High-dose therapy with allogeneic hematopoietic cell transplantation (HCT) offers effective control and potential cure of hematopoietic malignancies, but with the cost of associated morbidity that includes adverse effects on quality of life (QOL). A growing body of literature has characterized this impact. Longitudinal studies suggest early moderate… (More)
DOI: 10.1182/blood-2008-10-182592